Ray Dalio's CL Position Overview
Ray Dalio (via Bridgewater Associates, Lp) currently holds 63,103 shares of Colgate-Palmolive Company (CL) worth $4.99 M, representing 0.02% of the portfolio. First purchased in 2014-Q3, this long-term strategic position has been held for 39 quarters.
Based on 13F filings, Ray Dalio has maintained a strategic position in CL, demonstrating sustained confidence in this investment. Largest addition occurred in Q1 2022, adding 728,497 shares. Largest reduction occurred in Q3 2024, reducing 672,617 shares.
Analysis based on 13F filings available since 2013 Q2
Ray Dalio's Colgate-Palmolive Company (CL) Holding Value Over Time
Track share changes against reported price movement
Quarterly Colgate-Palmolive Company (CL) Trades by Ray Dalio
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -57,577 | Reduce 47.71% | 63,103 | $79.02 |
| Q3 2025 | +74,730 | Add 162.63% | 120,680 | $79.94 |
| Q2 2025 | -14,712 | Reduce 24.25% | 45,950 | $90.90 |
| Q1 2025 | -89,572 | Reduce 59.62% | 60,662 | $93.70 |
| Q4 2024 | -456,387 | Reduce 75.23% | 150,234 | $90.91 |
| Q3 2024 | -672,617 | Reduce 52.58% | 606,621 | $103.81 |
| Q2 2024 | -13,561 | Reduce 1.05% | 1.28 M | $97.04 |
| Q1 2024 | -254,087 | Reduce 16.43% | 1.29 M | $90.05 |
| Q4 2023 | -152,761 | Reduce 8.99% | 1.55 M | $79.71 |
| Q3 2023 | +60,019 | Add 3.66% | 1.7 M | $71.11 |
| Q2 2023 | -64,120 | Reduce 3.76% | 1.64 M | $77.04 |
| Q1 2023 | -188,986 | Reduce 9.98% | 1.7 M | $75.15 |
| Q4 2022 | -537,268 | Reduce 22.11% | 1.89 M | $78.79 |
| Q3 2022 | +139,805 | Add 6.10% | 2.43 M | $70.25 |
| Q2 2022 | -337,239 | Reduce 12.84% | 2.29 M | $80.14 |
| Q1 2022 | +728,497 | Add 38.36% | 2.63 M | $75.83 |
| Q4 2021 | +231,899 | Add 13.91% | 1.9 M | $85.34 |
| Q3 2021 | -6,986 | Reduce 0.42% | 1.67 M | $75.58 |
| Q2 2021 | +559,857 | Add 50.25% | 1.67 M | $81.35 |
| Q1 2021 | +212,672 | Add 23.59% | 1.11 M | $78.83 |
| Q4 2020 | +474,542 | Add 111.15% | 901,497 | $85.51 |
| Q3 2020 | +426,955 | New Buy | 426,955 | $77.15 |
| Q2 2020 | -31,361 | Sold Out | 0 | $0.00 |
| Q1 2020 | +31,361 | New Buy | 31,361 | $66.36 |
| Q4 2019 | -20,802 | Sold Out | 0 | $0.00 |
| Q3 2019 | +20,802 | New Buy | 20,802 | $73.50 |
| Q2 2019 | -3,145 | Sold Out | 0 | $0.00 |
| Q1 2019 | -576,766 | Reduce 99.46% | 3,145 | $68.68 |
| Q4 2018 | +488,966 | Add 537.65% | 579,911 | $59.52 |
| Q3 2018 | +90,945 | New Buy | 90,945 | $66.95 |
| Q1 2017 | -7,768 | Sold Out | 0 | $0.00 |
| Q4 2016 | +7,768 | New Buy | 7,768 | $65.40 |
| Q3 2016 | -11,300 | Sold Out | 0 | $0.00 |
| Q2 2016 | +11,300 | New Buy | 11,300 | $73.19 |
| Q1 2016 | -122,706 | Sold Out | 0 | $0.00 |
| Q4 2015 | +122,706 | New Buy | 122,706 | $66.62 |
| Q1 2015 | -53,471 | Sold Out | 0 | $0.00 |
| Q4 2014 | +31,665 | Add 145.21% | 53,471 | $69.20 |
| Q3 2014 | +21,806 | New Buy | 21,806 | $65.21 |
Ray Dalio's Colgate-Palmolive Company Investment FAQs
Ray Dalio first purchased Colgate-Palmolive Company (CL) in Q3 2014, acquiring 21,806 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Ray Dalio has held Colgate-Palmolive Company (CL) for 39 quarters since Q3 2014.
Ray Dalio's largest addition to Colgate-Palmolive Company (CL) was in Q1 2022, adding 2,627,436 shares worth $199.24 M.
According to the latest 13F filing for Q4 2025, Ray Dalio's firm, Bridgewater Associates, Lp, owns 63,103 shares of Colgate-Palmolive Company (CL), valued at approximately $4.99 M.
As of the Q4 2025 filing, Colgate-Palmolive Company (CL) represents approximately 0.02% of Ray Dalio's publicly disclosed stock portfolio, making it one of their key holdings.
Ray Dalio's peak holding in Colgate-Palmolive Company (CL) was 2,627,436 shares, as reported at the end of Q1 2022.